About Index Trending news
Analyze
Pricing
Neos Therapeutics, Inc.

Neos Therapeutics, Inc.

Neos Therapeutics, Inc.

Neos Therapeutics is an oral drug delivery company developing controlledtime-release technologies.

Elsewhere

Alexa global traffic share

Latest funding
Debt financing
$60,000,000
Employees

Team size

50+
Locations
HQ
Headquarters
Xconomy

Neos Therapeutics’ Controlled-Release ADHD Drug Get FDA Approval

Health
$60,000,000 Debt financing
GlobeNewswire News Room , biospace

Neos Therapeutics Announces Closing of $60 Million Term Debt Financing and First Quarter 2016 Financial Results

Xconomy

Neos Therapeutics, Maker of ADHD Drug Delivery System, Files IPO

Health